Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Prolonged norovirus shedding and the use of a rapid norovirus PCR to assess terminal room cleaning in immunocompromised patients.

Smith C, Casey A, Round SL, Malladi R, Holden E, Garvey MI.

J Hosp Infect. 2019 Feb 18. pii: S0195-6701(19)30089-1. doi: 10.1016/j.jhin.2019.02.006. [Epub ahead of print] No abstract available.

PMID:
30790606
2.

Effect of using fidaxomicin on recurrent Clostridium difficile infection.

Biggs M, Iqbal T, Holden E, Clewer V, Garvey MI.

J Hosp Infect. 2019 Jan 4. pii: S0195-6701(18)30723-0. doi: 10.1016/j.jhin.2018.12.018. [Epub ahead of print]

PMID:
30615960
3.

Wiping out MRSA: effect of introducing a universal disinfection wipe in a large UK teaching hospital.

Garvey MI, Wilkinson MAC, Bradley CW, Holden KL, Holden E.

Antimicrob Resist Infect Control. 2018 Dec 19;7:155. doi: 10.1186/s13756-018-0445-7. eCollection 2018.

4.

Tap out: reducing waterborne Pseudomonas aeruginosa transmission in an intensive care unit.

Garvey MI, Wilkinson MAC, Holden KL, Martin T, Parkes J, Holden E.

J Hosp Infect. 2018 Jul 31. pii: S0195-6701(18)30404-3. doi: 10.1016/j.jhin.2018.07.039. [Epub ahead of print]

PMID:
30071267
5.

How do we define recurrence in Clostridium difficile infection?

Bradley CW, Burdett H, Holden KL, Holden E, Garvey MI.

J Hosp Infect. 2018 Jul 26. pii: S0195-6701(18)30391-8. doi: 10.1016/j.jhin.2018.07.026. [Epub ahead of print] No abstract available.

PMID:
30055221
6.

Unmasking leading to a healthcare worker Mycobacterium tuberculosis transmission.

Holden KL, Bradley CW, Curran ET, Pollard C, Smith G, Holden E, Glynn P, Garvey MI.

J Hosp Infect. 2018 Dec;100(4):e226-e232. doi: 10.1016/j.jhin.2018.05.003. Epub 2018 May 9.

PMID:
29752996
7.

Outbreak of clonal complex 22 Panton-Valentine leucocidin-positive methicillin-resistant Staphylococcus aureus.

Garvey MI, Bradley CW, Holden KL, Oppenheim B.

J Infect Prev. 2017 Sep;18(5):224-230. doi: 10.1177/1757177417695647. Epub 2017 Mar 14. Erratum in: J Infect Prev. 2017 Nov;18(6):NP1.

8.

Can a toxin gene NAAT be used to predict toxin EIA and the severity of Clostridium difficile infection?

Garvey MI, Bradley CW, Wilkinson MAC, Holden E.

Antimicrob Resist Infect Control. 2017 Dec 19;6:127. doi: 10.1186/s13756-017-0283-z. eCollection 2017.

9.

Reducing Escherichia coli bacteraemia associated with catheter-associated urinary tract infections in the secondary care setting.

Bradley CW, Flavell H, Raybould L, McCoy H, Dempster L, Holden E, Garvey MI.

J Hosp Infect. 2018 Mar;98(3):236-237. doi: 10.1016/j.jhin.2017.11.018. Epub 2017 Dec 2. No abstract available.

PMID:
29203447
10.

Waterborne Pseudomonas aeruginosa transmission in a hematology unit?

Garvey MI, Bradley CW, Holden E.

Am J Infect Control. 2018 Apr;46(4):383-386. doi: 10.1016/j.ajic.2017.10.013. Epub 2017 Nov 28.

PMID:
29195780
11.

Selection of carbapenem-resistant Pseudomonas aeruginosa in a haematology unit?

Garvey MI, Bradley CW, Biggs MJ, Holden E, Gill MJ.

J Hosp Infect. 2018 Mar;98(3):238-240. doi: 10.1016/j.jhin.2017.10.023. Epub 2017 Nov 8. No abstract available.

PMID:
29126992
12.

Reduction in methicillin-resistant Staphylococcus aureus colonisation: impact of a screening and decolonisation programme.

Garvey MI, Winfield J, Wiley C, Reid M, Cooper M.

J Infect Prev. 2016 Nov;17(6):294-297. doi: 10.1177/1757177416661406. Epub 2016 Aug 4.

13.

Blossoming vancomycin-resistant enterococci infections.

Garvey MI, Bradley CW, Holden E.

J Hosp Infect. 2017 Dec;97(4):421-423. doi: 10.1016/j.jhin.2017.08.015. Epub 2017 Aug 24. No abstract available.

PMID:
28842262
14.

Using a vanA polymerase chain reaction to detect environmental contamination during a vancomycin-resistant enterococci outbreak.

Garvey MI, Bradley CW, Casey A, Clewer V, Holden E.

J Hosp Infect. 2017 Dec;97(4):419-421. doi: 10.1016/j.jhin.2017.08.014. Epub 2017 Aug 21. No abstract available.

PMID:
28838800
15.

Decontamination of an Extracorporeal Membrane Oxygenator Contaminated With Mycobacterium chimaera.

Garvey MI, Phillips N, Bradley CW, Holden E.

Infect Control Hosp Epidemiol. 2017 Oct;38(10):1244-1246. doi: 10.1017/ice.2017.163. Epub 2017 Aug 14.

PMID:
28803570
16.

Where to do water testing for Pseudomonas aeruginosa in a healthcare setting.

Garvey MI, Bradley CW, Holden E, Weibren M.

J Hosp Infect. 2017 Oct;97(2):192-195. doi: 10.1016/j.jhin.2017.06.014. Epub 2017 Jun 15.

PMID:
28625600
17.

Engineering waterborne Pseudomonas aeruginosa out of a critical care unit.

Garvey MI, Bradley CW, Wilkinson MAC, Bradley C, Holden E.

Int J Hyg Environ Health. 2017 Aug;220(6):1014-1019. doi: 10.1016/j.ijheh.2017.05.011. Epub 2017 May 31.

PMID:
28592358
18.

Microbiological problems and biofilms associated with Mycobacterium chimaera in heater-cooler units used for cardiopulmonary bypass.

Walker J, Moore G, Collins S, Parks S, Garvey MI, Lamagni T, Smith G, Dawkin L, Goldenberg S, Chand M.

J Hosp Infect. 2017 Jul;96(3):209-220. doi: 10.1016/j.jhin.2017.04.014. Epub 2017 Apr 26. Review.

PMID:
28532976
19.

A Year in the Life of a Contaminated Heater-Cooler Unit With Mycobacterium chimaera?

Garvey MI, Bradley CW, Walker J.

Infect Control Hosp Epidemiol. 2017 Jun;38(6):705-711. doi: 10.1017/ice.2017.64. Epub 2017 May 5.

PMID:
28473009
20.

Hand hygiene compliance targets: what are we actually targeting?

Bradley CW, Holden E, Garvey MI.

J Hosp Infect. 2017 Apr;95(4):359-360. doi: 10.1016/j.jhin.2017.02.004. Epub 2017 Feb 9. No abstract available.

PMID:
28237503
21.

Use of genome sequencing to identify hepatitis C virus transmission in a renal healthcare setting.

Garvey MI, Bradley CW, Holden KL, Hewins P, Ngui SL, Tedder R, Jumaa P, Smit E.

J Hosp Infect. 2017 Jun;96(2):157-162. doi: 10.1016/j.jhin.2017.01.002. Epub 2017 Jan 16.

PMID:
28196726
22.

The Effect of Universal Decolonization With Screening in Critical Care to Reduce MRSA Across an Entire Hospital.

Bradley CW, Wilkinson MA, Garvey MI.

Infect Control Hosp Epidemiol. 2017 Apr;38(4):430-435. doi: 10.1017/ice.2017.4. Epub 2017 Feb 6.

PMID:
28162098
23.

Using a carbapenemase-producing organism polymerase chain reaction to rapidly determine the efficacy of terminal room disinfection.

Garvey MI, Bradley CW, Casey AL.

J Hosp Infect. 2017 Mar;95(3):329-330. doi: 10.1016/j.jhin.2016.12.022. Epub 2017 Jan 4. No abstract available.

PMID:
28131645
24.

Improved understanding of an outbreak of meticillin-resistant Staphylococcus aureus in a regional burns centre via whole-genome sequencing.

Garvey MI, Pichon B, Bradley CW, Moiemen NS, Oppenheim B, Kearns AM.

J Hosp Infect. 2016 Dec;94(4):401-404. doi: 10.1016/j.jhin.2016.09.013. Epub 2016 Sep 23. No abstract available.

PMID:
27729168
25.

The risks of contamination from tap end filters.

Garvey MI, Bradley CW, Jumaa P.

J Hosp Infect. 2016 Nov;94(3):282-283. doi: 10.1016/j.jhin.2016.08.006. Epub 2016 Aug 18. No abstract available.

PMID:
27613442
26.

Evaluating the risks of wash hand basin tap disinfection.

Garvey MI, Bradley CR, Bradley CW.

J Hosp Infect. 2016 Sep;94(1):21-2. doi: 10.1016/j.jhin.2016.06.020. Epub 2016 Jul 2. No abstract available.

PMID:
27440404
27.

Continued transmission of Pseudomonas aeruginosa from a wash hand basin tap in a critical care unit.

Garvey MI, Bradley CW, Tracey J, Oppenheim B.

J Hosp Infect. 2016 Sep;94(1):8-12. doi: 10.1016/j.jhin.2016.05.004. Epub 2016 May 13.

PMID:
27249962
28.

Decontamination of heater-cooler units associated with contamination by atypical mycobacteria.

Garvey MI, Ashford R, Bradley CW, Bradley CR, Martin TA, Walker J, Jumaa P.

J Hosp Infect. 2016 Jul;93(3):229-34. doi: 10.1016/j.jhin.2016.02.007. Epub 2016 Mar 28.

PMID:
27112044
29.

Environmental decontamination following occupancy of a burns patient with multiple carbapenemase-producing organisms.

Garvey MI, Bradley CW, Jumaa P.

J Hosp Infect. 2016 Jun;93(2):136-40. doi: 10.1016/j.jhin.2016.01.006. Epub 2016 Jan 25.

PMID:
26895617
30.

Comparative antibacterial effects of moxifloxacin and levofloxacin on Streptococcus pneumoniae strains with defined mechanisms of resistance: impact of bacterial inoculum.

Bowker KE, Garvey MI, Noel AR, Tomaselli SG, Macgowan AP.

J Antimicrob Chemother. 2013 May;68(5):1130-8. doi: 10.1093/jac/dks537. Epub 2013 Jan 29.

PMID:
23361641
31.

Medicinal plant extracts with efflux inhibitory activity against Gram-negative bacteria.

Garvey MI, Rahman MM, Gibbons S, Piddock LJ.

Int J Antimicrob Agents. 2011 Feb;37(2):145-51. doi: 10.1016/j.ijantimicag.2010.10.027. Epub 2010 Dec 30.

PMID:
21194895
32.

Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.

Garvey MI, Baylay AJ, Wong RL, Piddock LJ.

Antimicrob Agents Chemother. 2011 Jan;55(1):190-6. doi: 10.1128/AAC.00672-10. Epub 2010 Oct 11.

33.

Natural and synthetic compounds such as trimethoprim behave as inhibitors of efflux in Gram-negative bacteria.

Piddock LJ, Garvey MI, Rahman MM, Gibbons S.

J Antimicrob Chemother. 2010 Jun;65(6):1215-23. doi: 10.1093/jac/dkq079. Epub 2010 Mar 19.

PMID:
20304975
34.

Exposure of Escherichia coli and Salmonella enterica serovar Typhimurium to triclosan induces a species-specific response, including drug detoxification.

Bailey AM, Constantinidou C, Ivens A, Garvey MI, Webber MA, Coldham N, Hobman JL, Wain J, Woodward MJ, Piddock LJ.

J Antimicrob Chemother. 2009 Nov;64(5):973-85. doi: 10.1093/jac/dkp320. Epub 2009 Sep 16.

PMID:
19759044
35.

The efflux pump inhibitor reserpine selects multidrug-resistant Streptococcus pneumoniae strains that overexpress the ABC transporters PatA and PatB.

Garvey MI, Piddock LJ.

Antimicrob Agents Chemother. 2008 May;52(5):1677-85. doi: 10.1128/AAC.01644-07. Epub 2008 Mar 24.

Supplemental Content

Loading ...
Support Center